These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11986378)

  • 41. Astrocyte mGlu(2/3)-mediated cAMP potentiation is calcium sensitive: studies in murine neuronal and astrocyte cultures.
    Moldrich RX; Apricó K; Diwakarla S; O'Shea RD; Beart PM
    Neuropharmacology; 2002 Aug; 43(2):189-203. PubMed ID: 12213273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors.
    Kingston AE; O'Neill MJ; Bond A; Bruno V; Battaglia G; Nicoletti F; Harris JR; Clark BP; Monn JA; Lodge D; Schoepp DD
    Ann N Y Acad Sci; 1999; 890():438-49. PubMed ID: 10668448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exacerbation of neuronal cell death by activation of group I metabotropic glutamate receptors: role of NMDA receptors and arachidonic acid release.
    Allen JW; Vicini S; Faden AI
    Exp Neurol; 2001 Jun; 169(2):449-60. PubMed ID: 11358458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus.
    Doherty AJ; Palmer MJ; Henley JM; Collingridge GL; Jane DE
    Neuropharmacology; 1997 Feb; 36(2):265-7. PubMed ID: 9144665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes.
    Frati C; Marchese C; Fisichella G; Copani A; Nasca MR; Storto M; Nicoletti F
    J Cell Physiol; 2000 Jun; 183(3):364-72. PubMed ID: 10797311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of metabotropic glutamate receptor subclasses in modulation of adenylyl cyclase activity by a nootropic NS-105.
    Hirouchi M; Oka M; Itoh Y; Ukai Y; Kimura K
    Eur J Pharmacol; 2000 Jan; 387(1):9-17. PubMed ID: 10633154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A slow excitatory postsynaptic current mediated by a novel metabotropic glutamate receptor in CA1 pyramidal neurons.
    Sheng N; Yang J; Silm K; Edwards RH; Nicoll RA
    Neuropharmacology; 2017 Mar; 115():4-9. PubMed ID: 27567940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Group II metabotropic glutamate receptors reduce excitatory but not inhibitory neurotransmission in rat barrel cortex in vivo.
    Cahusac PM; Wan H
    Neuroscience; 2007 Apr; 146(1):202-12. PubMed ID: 17346894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions between NMDA receptors and mGlu5 receptors expressed in HEK293 cells.
    Collett VJ; Collingridge GL
    Br J Pharmacol; 2004 Jul; 142(6):991-1001. PubMed ID: 15210575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physiological activation of mGlu5 receptors supports the ion channel function of NMDA receptors in hippocampal LTD induction in vivo.
    O'Riordan KJ; Hu NW; Rowan MJ
    Sci Rep; 2018 Mar; 8(1):4391. PubMed ID: 29535352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional selectivity induced by mGlu₄ receptor positive allosteric modulation and concomitant activation of Gq coupled receptors.
    Yin S; Zamorano R; Conn PJ; Niswender CM
    Neuropharmacology; 2013 Mar; 66():122-32. PubMed ID: 22426233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms underlying prelimbic prefrontal cortex mGlu
    Joffe ME; Santiago CI; Stansley BJ; Maksymetz J; Gogliotti RG; Engers JL; Nicoletti F; Lindsley CW; Conn PJ
    Neuropharmacology; 2019 Jan; 144():19-28. PubMed ID: 30326237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Type I and II metabotropic glutamate receptors modulate periaqueductal grey glycine release: interaction between mGlu2/3 and A1 adenosine receptors.
    de Novellis V; Marabese I; Uliano R; Palazzo E; Scafuro A; sca Rossi F; Maione S
    Neuropharmacology; 2002 Dec; 43(7):1061-9. PubMed ID: 12504911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. mGlu
    Turner BD; Rook JM; Lindsley CW; Conn PJ; Grueter BA
    Neuropsychopharmacology; 2018 Sep; 43(10):2075-2082. PubMed ID: 29654259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in mGlu5 receptor-dependent synaptic plasticity and coupling to homer proteins in the hippocampus of Ube3A hemizygous mice modeling angelman syndrome.
    Pignatelli M; Piccinin S; Molinaro G; Di Menna L; Riozzi B; Cannella M; Motolese M; Vetere G; Catania MV; Battaglia G; Nicoletti F; Nisticò R; Bruno V
    J Neurosci; 2014 Mar; 34(13):4558-66. PubMed ID: 24672001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The metabotropic glutamate receptor mGlu5 controls the onset of developmental apoptosis in cultured cerebellar neurons.
    Copani A; Casabona G; Bruno V; Caruso A; Condorelli DF; Messina A; Di Giorgi Gerevini V; Pin JP; Kuhn R; Knöpfel T; Nicoletti F
    Eur J Neurosci; 1998 Jun; 10(6):2173-84. PubMed ID: 9753103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of the Interaction Between Group I Metabotropic Glutamate Receptors and PDZ-Domain Proteins Prevents Hippocampal Long-Term Depression, but Not Long-Term Potentiation.
    Neyman S; Braunewell KH; O'Connell KE; Dev KK; Manahan-Vaughan D
    Front Synaptic Neurosci; 2019; 11():13. PubMed ID: 31057390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cooperation between mglu receptors: a depressing mechanism?
    Cho K; Bashir ZI
    Trends Neurosci; 2002 Aug; 25(8):405-11. PubMed ID: 12127757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Place field stability requires the metabotropic glutamate receptor, mGlu5.
    Zhang S; Manahan-Vaughan D
    Hippocampus; 2014 Nov; 24(11):1330-40. PubMed ID: 24910241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Constitutively active group I mGlu receptors and PKMzeta regulate synaptic transmission in developing perirhinal cortex.
    Panaccione I; King R; Molinaro G; Riozzi B; Battaglia G; Nicoletti F; Bashir ZI
    Neuropharmacology; 2013 Mar; 66():143-50. PubMed ID: 23357951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.